BLESSTIA SYNTHESIS CLEMATIS 106
BLESSTIA SYNTHESIS CLEMATIS 106
Starting material for the compounding of officinal homeopathic medicine, according to the official homeopathic pharmacopoeias, without indications / conclusive description resulting from repertorizing:
Support of the organism that is during treatment or after treatment for extended malignancy.
Dosage: 3 tablets daily orally.
Specific information: Side-effects never manifested. Never manifested synergy when administered simultaneously with any chemical or other medicine.
Recommendation: Before starting any non prescription medicine, your health condition must be clinically diagnosed and fully examined through laboratory testing.
Attention: Consult your physician immediately if symptoms persist or worsen.
Product Description
Scientific documentation:
- Repertorizing hints as of appendix a:
General, clinical conditions, cancerous affections / general, clinical conditions, degeneration of tissues, tendency to / tumors, cephalematoma, cystic, cholosteatoma, osteoma, scirrhus in vagina, epithelioma, lipoma, fibroid, lipoma, lymphoma, sarcoma, scirrhus, steatoma, wens / general, lassitude / emaciation, marasmus, appetite ravenous with, cancerous affections in, loss of animal fluid from, old people in / tumors / emaciation, marasmus, appetite ravenous with, cancerous affections in, loss of animal fluid from, old people in / tumors / pain, cancerous secretions in / cancer / cancerous cachexia / carcinoma / cancer, carcinoma / cancerous cachexia, cancer, pains of / generals, pain, cancerous affections in / general conditions, ailments from, operation of injuries / tissues, breasts, tumors in, cancer / abdomen, inflammation, inflammatory irritation, by metastasis from gout / ears, metastasis from other parts / male sexual organs, testicle, metastasis / nerves, convulsions, brain, metastasis from other organs / stool and rectum, diarrhoea, drain, hydrocephaloid, sudden metastasis from bowels /
- Materia medica reference as of appendix b